Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 201 - 250 out of 2,238

Document Document Title
WO/2004/091278A2
The present invention comprises an organic acid salt of gabapentin, wherein the organic acid is tartaric acid, ethanedisulfonic acid, or maleic acid. Methods for modulating the solubility and dose response of gabapentin are discussed. Me...  
WO/2004/092145A1
Alpha substituted carboxylic acids of formula (I): wherein R' and R2 are as defined in the specification and R3 is A) formula (II); B) formula (III); C) formula (IV); and D) formula (V); wherein Y, Art, Are, AP, R4, R5, R6, R7, R6, R9, R...  
WO2004010512A3
Novel heterodiamondoids are disclosed. These heterodiamondoids are diamondoids that include heteroatoms in the diamond lattice structure. The heteroatoms may be either electron donating, such that an n-type heterodiamondoid is created, o...  
WO/2004/085366A1
Two compounds namely ent-pimmarane 8(14), 15-diene-19 oic acid (compound 1) and ent-pimmarane 7(8), 9(11),15-diene-19 oic acid (compound 2) were isolated from Lavatera cachmeriania, these compounds, in vitro, significantly inhibited the ...  
WO/2004/076349A1
Disclosed and claimed herein are e,e,e malonic acid/acetic acid tri-adduct of buckminsterfullerene of the general formula C60R3, wherein each R is independently selected from groups of the formula -CR1R2 wherein each R1 and R2 is indepen...  
WO/2004/063169A1
A compound having the following formula (I): wherein R¿1? is N-containing heterocyclic ring optionally substituted with one or more suitable substituent(s), R¿2? is hydroxyamino, R¿3? is hydrogen or a suitable substituent, L¿1? is -(...  
WO/2004/046079A1
The invention relates to optionally isolated and/or purified enantiomers of 2-heptylcyclopropyl-1-carboxylic acid, in addition to mixtures of two, three or all enantiomers of 2-heptylcyclopropyl-1-carboxylic acid, which are used as perfu...  
WO2004031126A3
A process for synthesis of 1-(aminomethyl)cyclohexane acetic acid hydrochloride (Gabapentin hydrochloride) comprising: a) Reaction of a mixture of acetic anhydride/ammonium acetate with 1,1-cyclohexane­diacetic acid to yield 3,3-pentame...  
WO2002079137A9
Novel compounds are disclosed that have specific chemical structures, and prodrug esters and acid-addition salts thereof, that are useful as Interleukin-1 and Tumor Necrosis Factor-a modulators, and thus are useful in the treatment of va...  
WO/2004/037240A1
The present invention relates to the use of compounds of Formula (I) for the treatment of epilepsy, bipolar disorder, psychiatric disorders, migraine, pain, or movement disorders, and to provide neuroprotection.  
WO/2004/037241A1
The present invention relates to the use of compounds of formula (I) for the treatment of epilepsy, bipolar disorder, psychiatric disorders, migraine, pain, or movement disorders, and to provide neuroprotection.  
WO/2004/031126A2
A process for synthesis of 1-(aminomethyl)cyclohexane acetic acid hydrochloride (Gabapentin hydrochloride) comprising: a) Reaction of a mixture of acetic anhydride/ammonium acetate with 1,1-cyclohexane­diacetic acid to yield 3,3-pentame...  
WO2004000763A3
The invention concerns a method for preparing an unsaturated carboxylic acid from the corresponding aldehyde. More particularly, the invention aims at preparing an aliphatic carboxylic acid having at least an unsaturation conjugated with...  
WO2004010512A9
Novel heterodiamondoids are disclosed. These heterodiamondoids are diamondoids that include heteroatoms in the diamond lattice structure. The heteroatoms may be either electron donating, such that an n-type heterodiamondoid is created, o...  
WO/2004/009577A1
This invention is related to heteroatom containing diamondoids (i.e., 'heterodiamondoids' ) which are compounds having a diamondoid nucleus in which one or more of the diamondoid nucleus carbons has been substitutionally replaced with a ...  
WO/2004/010512A2
Novel heterodiamondoids are disclosed. These heterodiamondoids are diamondoids that include heteroatoms in the diamond lattice structure. The heteroatoms may be either electron donating, such that an n-type heterodiamondoid is created, o...  
WO2003072802A3
The instant invention is a method for increasing a metazoan's lifespan, comprising administering a carboxylated derivative of a C60 fullerene. The instant invention further is a process for extending a metazoan's lifespan by administerin...  
WO2003087174A3
The invention relates to defined carbocyclic and oxacarbocyclic fumaric acid oligomers. The invention also relates to the use thereof for producing a drug and to drugs comprising the inventive compounds.  
WO/2004/000763A2
The invention concerns a method for preparing an unsaturated carboxylic acid from the corresponding aldehyde. More particularly, the invention aims at preparing an aliphatic carboxylic acid having at least an unsaturation conjugated with...  
WO/2003/087174A2
The invention relates to defined carbocyclic and oxacarbocyclic fumaric acid oligomers. The invention also relates to the use thereof for producing a drug and to drugs comprising the inventive compounds.  
WO2003053915A3
This invention relates to compounds of the Formula (I):(Chemical formula should be inserted here as it appears on abstract in paper form)(I)or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the tre...  
WO/2003/074063A1
The invention relates to a process for producing a fraction enriched upto 100 % of 3-O-acetyl-11-keto-β-boswellic acid. An organic solvent extract of gum resin from Boswellia species is first subjected to oxidation and then acetylation ...  
WO/2003/072802A2
The instant invention is a method for increasing a metazoan's lifespan, comprising administering a carboxylated derivative of a C60 fullerene. The instant invention further is a process for extending a metazoan's lifespan by administerin...  
WO/2003/062185A1
The invention relates to methods for producing substituted acrylic acid esters and to the use of the latter for producing substituted $g(g)-amino acids, such as gabapentin and pregabalin. The substituted acrylic acid esters are produced ...  
WO/2003/053915A2
This invention relates to compounds of the Formula (I):(Chemical formula should be inserted here as it appears on abstract in paper form)(I)or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the tre...  
WO/2003/053905A1
A process for the production of 1R pyrethroid esters of formula (IIIA) or (IIIB), wherein A and B are independently chlorine or bromine or one of A or B is chlorine and the other is trifluoromethyl and R is a pyrethroid alcohol fragment,...  
WO/2003/045962A1
The present invention relates to a novol class of supermolecules carboplatinum derivatives represented by general formula (I), wherein B is a polycarboxylic represented by general formula (II), wherein (R1) and (R2) and (n) is defined as...  
WO/2003/040230A1
Compounds and compositions comprising specific metal salts of bicyclo[2.2.1]heptane dicarboxylate salts in order to provide highly desirable properties within polyolefin articles are provided. The inventive salts and derivatives thereof ...  
WO/2003/006413A1
Novel norbornene derivatives bearing fluorinated ketone or fluorinated alcohol moieties attached directly to norbornene skeleton, which are useful as material of chemically amplified photoresists for F2 laser lithography having excellent...  
WO/2002/098967A1
Compounds of and compositions comprising specific salts of saturated [2.2.2] dicarboxylate in order to provide highly desirable properties within thermoplastic (e.g., polyolefin) articles are provided. The inventive salts and derivatives...  
WO/2002/094759A1
Bicyclic nucleator compounds that provide highly versatile nucleation benefits for different polyolefins are provided. Such nucleator compounds provide very high peak crystallization temperatures and significantly reduced crystallization...  
WO2002079137A8
Novel compounds are disclosed that have specific chemical structures, and prodrug esters and acid-addition salts thereof, that are useful as Interleukin-1 and Tumor Necrosis Factor-a modulators, and thus are useful in the treatment of va...  
WO/2002/085839A1
The compounds of the instant invention are bicyclic or tricyclic amino acids useful in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, arthritis...  
WO/2002/079137A1
Novel compounds are disclosed that have specific chemical structures, and prodrug esters and acid-addition salts thereof, that are useful as Interleukin-1 and Tumor Necrosis Factor-a modulators, and thus are useful in the treatment of va...  
WO/2002/079134A1
The present invention relates to a process for the manufacture of compounds of general formula (I), wherein R?2a¿, R?2b¿ are, independently from each other, hydrogen; halogen; lower alkoxy; cyano; -COOH; lower alkoxycarbonyl; or lower ...  
WO/2002/077092A1
Compounds and compositions comprising specific metal salts of bicyclo[2.2.1]heptane dicarboxylate salts in order to provide highly desirable properties within polyolefin articles are provided. The inventive salts and derivatives thereof ...  
WO2002057201A3
Higher diamondoid derivatives capable of taking part in polymerization reactions are disclosed as are intermediates to these derivatives, polymers formed from these derivatives and methods for preparing the polymers.  
WO/2002/066412A1
The invention relates to a method for producing cyclohexane dicarboxylic acids or derivatives thereof, e.g esters and anhydrides, wherein diene maleic acid anhydride mixtures, especially mixtures of butadiene maleic acid anhydrides or mi...  
WO/2002/057201A2
Higher diamondoid derivatives capable of taking part in polymerization reactions are disclosed as are intermediates to these derivatives, polymers formed from these derivatives and methods for preparing the polymers.  
WO/2002/050013A1
A carboxylic acid compound having cyclopropane ring(s) of the formula (I): wherein R is alkyl or alkenyl optionally having one or more 1,2-cyclopropylene in a carbon chain and/or optionally having cyclopropyl at the end of a chain,X is a...  
WO2001056959B1
A substance including the chemical structures of bicyclo[3.2.1]octan or the chemical structures of kaurene for the use in a dietary supplementation or as a constituent in a medicament for the treatment of non-insulin dependent diabetes m...  
WO/2002/006202A1
A process for producing compounds of formula (VIIa) and (VIIb) wherein X is a leaving group; Y and Y?1¿ are idependently Cl or Br; and Z is Cl, Br or a haloalkyl group which process comprises a) reacting a compound of formula (VII) wher...  
WO/2001/096273A1
A process is provided, by which 1-substituted-cyclo-hexanecarbonyl halides of the general formula [1] can be prepared industrially practically at an extremely low cost: [1] wherein R is linear or branched C¿1-10? alkyl, C¿3-10? cycloal...  
WO/2001/092200A1
The invention relates to a novel process for the preparation of certain cyclopropyl carboxylic acid esters and other cyclopropyl carboxylic acid derivatives; a novel process for the preparation of dimethylsulfoxonium methylide and dimeth...  
WO/2001/064696A1
The present invention relates to dicarboxylato diammine platinum derivatives of formula (I), wherein R?1¿ and R?2¿ are defined as in the description, to method for preparing them, and to antitumor chemical compositions comprising them....  
WO/2001/056959A1
A substance including the chemical structures of bicyclo[3.2.1]octan or the chemical structures of kaurene for the use in a dietary supplementation or as a constituent in a medicament for the treatment of non-insulin dependent diabetes m...  
WO2001009076A3
This invention relates to new RAR selective retinoid agonists of formula (I) wherein the symbols are as defined in the specification to their pharmaceutically acceptable salts, individual isomers or to a racemic or non-racemic mixture; t...  
WO/2001/051455A1
Cyanohydrin homologation of the 4-cyanocyclohexanone (D) provides a 4-cyanocyclohexanoic acid (I).  
WO/2001/034592A1
The invention relates to 5-halo-4-fluoro-4,7,7-trimethyl-3-oxabicyclo[4.1.0]heptane-2 -ones, to a method for their production and to their use in the production of cyclopropane carboxylic acids. The invention relates to the compounds of ...  
WO/2001/010822A1
This invention relates to a method for preparing certain acids of formula (I) via a chloroepoxy ester, which are useful as phosphodiesterase 4 inhibitors.  

Matches 201 - 250 out of 2,238